Willmer T, Damerell V, Smyly S, Sims D, Du Toit M, Ncube S, et al. Targeting the oncogenic TBX3:nucleolin complex to treat multiple sarcoma subtypes. Am J Cancer Res. 2021;11(11):5680-700.
Targeting the oncogenic TBX3:nucleolin complex to treat multiple sarcoma subtypes.
By Content Specialist|2022-06-20T08:31:33+02:00June 20, 2022|2021 Publication, 2021: October to December|Comments Off on Targeting the oncogenic TBX3:nucleolin complex to treat multiple sarcoma subtypes.
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not Protection